Skip to main content
SpringerLink
Log in

Cancer Registries: Can We Improve the Quality of Thyroid Cancer Data?

  • Endocrine Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Cancer registries are used to report cancer care trends and outcomes. Information from these data sets is utilized to craft practice guidelines and management recommendations. Limited knowledge is available regarding the quality of the data contained within registries. We sought to determine the accuracy of a single variable, ‘surgery of the primary site’, in the Tennessee Cancer Registry (TCR).

Methods

A retrospective review of the TCR thyroid database was performed. Hospital facilities were classified as either Commission on Cancer (CoC) or non-CoC accredited. Certified Tumor Registrars at the TCR reviewed the abstracted text and/or telephoned the reporting facility staff to confirm the definitive thyroid procedure.

Results

A total of 921 thyroid cancer cases, diagnosed/treated at TN facilities during 2004–2011, were coded with thyroid lobectomy (TL). Overall, 369 (40 %) were incorrectly coded, of which 247(67 %) were changed to total thyroidectomy. The majority of cases (80 %) were reported by CoC facilities. When compared by facility type, 42 % of records submitted from CoC facilities contained incorrect codes for the variable ‘surgery of the primary site’ TL compared with 34 % of records submitted by non-CoC facilities (p = 0.047).

Conclusion

In this study of the TCR, 40 % of records contained inaccurate coding of the variable ‘surgery of the primary site’. Upon validation, 27 % of all records were changed from TL to total thyroidectomy. The rate of incorrect coding was higher in CoC reporting facilities than in non-CoC facilities. Using text-to-code re-abstraction audits and facility contact these discrepancies can be validated and corrected to improve data quality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. American College of Surgeons. Commission on Cancer: Cancer Program Standards (2016 edition). https://www.facs.org/quality-programs/cancer/coc/standards.

  2. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kiernan CM, Parikh AA, Parks LL, Solorzano CC. Use of radioiodine after thyroid lobectomy in patients with differentiated thyroid cancer: does it change outcomes? J Am Coll Surg. 2015;220(4):617–25.

    Article  PubMed  Google Scholar 

  4. Goffredo P, Thomas SM, Adam MA, Sosa JA, Roman SA. Impact of timeliness of resection and thyroidectomy margin status on survival for patients with anaplastic thyroid cancer: an analysis of 335 cases. Ann Surg Oncol. 2015;22(13):4166–74.

    Article  PubMed  Google Scholar 

  5. Shaha AR. Anaplastic thyroid cancer: large database, cautious interpretations. Ann Surg Oncol. 2015;22(13):4113–4.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Adam MA, Pura J, Goffredo P, Dinan MA, Hyslop T, Reed SD, et al. Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. J Clin Endocrinol Metab. 2015;100(1):115–21.

    Article  CAS  PubMed  Google Scholar 

  7. Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg. 2014;260(4):601–5; discussion 5–7.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Bilimoria KY, Bentrem DJ, Linn JG, Freel A, Yeh JJ, Stewart AK, et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery. 2007;142(6):906–13; discussion 913.e1-2.

    Article  PubMed  Google Scholar 

  9. Haymart MR, Banerjee M, Stewart AK, Koenig RJ, Birkmeyer JD, Griggs JJ. Use of radioactive iodine for thyroid cancer. JAMA. 2011;306(7):721–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 [see comments]. Cancer. 1998;83(12):2638–48.

  11. Mendelsohn AH, Elashoff DA, Abemayor E, St John MA. Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg. 2010;136(11):1055–61.

    Article  PubMed  Google Scholar 

  12. Roman S, Lin R, Sosa JA. Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases. Cancer. 2006;107(9):2134–42.

    Article  PubMed  Google Scholar 

  13. North American Association of Central Cancer Registries. Standards for Cancer Registries Volume II: Data Standards and Data Dictionary. Record Layout Version 13, 17th ed. https://www.naaccr.org/Applications/ContentReader/Archive/13/Chap01.html.

  14. Shaha AR. The National Cancer Data Base Report on thyroid carcinoma: reflections of practice patterns. Cancer. 1998;83(12):2434–6.

  15. Shaha AR. Extent of surgery for papillary thyroid carcinoma: the debate continues. Comment on “surgery for papillary thyroid carcinoma”. Arch Otolaryngol Head Neck Surg. 2010;136(11):1061–3.

    Article  PubMed  Google Scholar 

  16. Commission on Cancer. Facility Oncology Registry Data Standards. Chicago: American College of Surgeons; 2016.

    Google Scholar 

  17. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL. Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002;40(8 Suppl):IV-43–IV-8.

    Google Scholar 

Download references

Funding

Colleen M. Kiernan received salary support from National Institutes of Health (NIH) T32 Surgical Oncology Training Grant (#5T3CA106183-08).

Author information

Authors and Affiliations

  1. Department of Surgery, Vanderbilt University, 1161 21st Ave, CCC-4312 MCN, Nashville, TN, USA

    Colleen M. Kiernan MD, MPH

  2. Tennessee State Department of Health, Tennessee Cancer Registry, Nashville, USA

    Martin A. Whiteside PhD, MSPH

  3. Division of Surgical Oncology and Endocrine Surgery, Vanderbilt University Medical Center, Nashville, TN, USA

    Carmen C. Solorzano MD

Authors
  1. Colleen M. Kiernan MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Martin A. Whiteside PhD, MSPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carmen C. Solorzano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Colleen M. Kiernan MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kiernan, C.M., Whiteside, M.A. & Solorzano, C.C. Cancer Registries: Can We Improve the Quality of Thyroid Cancer Data?. Ann Surg Oncol 24, 1202–1207 (2017). https://doi.org/10.1245/s10434-016-5612-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-016-5612-6

Keywords

Search

Navigation